1. Home
  2. WEX vs KRYS Comparison

WEX vs KRYS Comparison

Compare WEX & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEX
  • KRYS
  • Stock Information
  • Founded
  • WEX 1983
  • KRYS 2015
  • Country
  • WEX United States
  • KRYS United States
  • Employees
  • WEX N/A
  • KRYS N/A
  • Industry
  • WEX Business Services
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WEX Consumer Discretionary
  • KRYS Health Care
  • Exchange
  • WEX Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • WEX 5.8B
  • KRYS 4.7B
  • IPO Year
  • WEX 2005
  • KRYS 2017
  • Fundamental
  • Price
  • WEX $145.33
  • KRYS $196.65
  • Analyst Decision
  • WEX Hold
  • KRYS Strong Buy
  • Analyst Count
  • WEX 13
  • KRYS 9
  • Target Price
  • WEX $172.92
  • KRYS $214.22
  • AVG Volume (30 Days)
  • WEX 396.3K
  • KRYS 316.5K
  • Earning Date
  • WEX 10-29-2025
  • KRYS 11-03-2025
  • Dividend Yield
  • WEX N/A
  • KRYS N/A
  • EPS Growth
  • WEX N/A
  • KRYS 275.72
  • EPS
  • WEX 7.64
  • KRYS 6.66
  • Revenue
  • WEX $2,624,500,000.00
  • KRYS $373,164,000.00
  • Revenue This Year
  • WEX $1.59
  • KRYS $34.33
  • Revenue Next Year
  • WEX $4.91
  • KRYS $48.04
  • P/E Ratio
  • WEX $19.05
  • KRYS $29.71
  • Revenue Growth
  • WEX N/A
  • KRYS 54.51
  • 52 Week Low
  • WEX $110.45
  • KRYS $122.80
  • 52 Week High
  • WEX $191.43
  • KRYS $212.98
  • Technical
  • Relative Strength Index (RSI)
  • WEX 37.30
  • KRYS 59.19
  • Support Level
  • WEX $142.19
  • KRYS $194.92
  • Resistance Level
  • WEX $150.84
  • KRYS $212.98
  • Average True Range (ATR)
  • WEX 5.47
  • KRYS 8.35
  • MACD
  • WEX -0.69
  • KRYS -0.17
  • Stochastic Oscillator
  • WEX 14.75
  • KRYS 42.14

About WEX WEX Inc. common stock

WEX Inc is a provider of corporate payment solutions. The company operates three business segments: Mobility, Benefits, and Corporate Payments. Mobility segment, the top segment by revenue, provides fleet vehicle payment solutions, transaction processing, and information management services for commercial and government fleets. The Corporate Payments segment offers business-to-business payment processing and transaction monitoring services. The Benefits segment generates revenue from healthcare payment products and its consumer-directed software platform. The company's prime end market is the United States of America.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: